
Donna A. Jagoe
Examiner (ID: 8925)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1614, 1619 |
| Total Applications | 644 |
| Issued Applications | 169 |
| Pending Applications | 182 |
| Abandoned Applications | 293 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5473067
[patent_doc_number] => 20090246233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists'
[patent_app_type] => utility
[patent_app_number] => 12/480287
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16648
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0246/20090246233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12480287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/480287 | Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists | Jun 7, 2009 | Abandoned |
Array
(
[id] => 5509238
[patent_doc_number] => 20090082445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'GOSSYPOL CO-CRYSTALS AND THE USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/242419
[patent_app_country] => US
[patent_app_date] => 2008-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11738
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20090082445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12242419
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/242419 | GOSSYPOL CO-CRYSTALS AND THE USE THEREOF | Sep 29, 2008 | Abandoned |
Array
(
[id] => 5551811
[patent_doc_number] => 20090285797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM'
[patent_app_type] => utility
[patent_app_number] => 12/237713
[patent_app_country] => US
[patent_app_date] => 2008-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 59
[patent_figures_cnt] => 59
[patent_no_of_words] => 21335
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285797.pdf
[firstpage_image] =>[orig_patent_app_number] => 12237713
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/237713 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM | Sep 24, 2008 | Abandoned |
Array
(
[id] => 4663146
[patent_doc_number] => 20080254053
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'Protocol for treatment of diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/157807
[patent_app_country] => US
[patent_app_date] => 2008-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2378
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254053.pdf
[firstpage_image] =>[orig_patent_app_number] => 12157807
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/157807 | Protocol for treatment of diabetes | Jun 12, 2008 | Abandoned |
Array
(
[id] => 4778379
[patent_doc_number] => 20080286377
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'ANTI-RESORPTIVE BONE CEMENTS AND ALLOGENEIC, AUTOGRAFIC, AND XENOGRAFIC BONE GRAFTS'
[patent_app_type] => utility
[patent_app_number] => 12/135484
[patent_app_country] => US
[patent_app_date] => 2008-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16635
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20080286377.pdf
[firstpage_image] =>[orig_patent_app_number] => 12135484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/135484 | ANTI-RESORPTIVE BONE CEMENTS AND ALLOGENEIC, AUTOGRAFIC, AND XENOGRAFIC BONE GRAFTS | Jun 8, 2008 | Abandoned |
Array
(
[id] => 4887686
[patent_doc_number] => 20080262018
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Treating allergic and inflammatory conditions'
[patent_app_type] => utility
[patent_app_number] => 12/155250
[patent_app_country] => US
[patent_app_date] => 2008-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8240
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262018.pdf
[firstpage_image] =>[orig_patent_app_number] => 12155250
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/155250 | Treating allergic and inflammatory conditions | May 29, 2008 | Issued |
Array
(
[id] => 4823374
[patent_doc_number] => 20080227818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-18
[patent_title] => 'USE OF SAREDUTANT OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS IN THE TREATMENT OF MIXED ANXIETY-DEPRESSION DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/124262
[patent_app_country] => US
[patent_app_date] => 2008-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1671
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20080227818.pdf
[firstpage_image] =>[orig_patent_app_number] => 12124262
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/124262 | USE OF SAREDUTANT OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS IN THE TREATMENT OF MIXED ANXIETY-DEPRESSION DISORDERS | May 20, 2008 | Abandoned |
Array
(
[id] => 5284528
[patent_doc_number] => 20090098203
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-16
[patent_title] => 'Mucoadhesive Tetracycline Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/122232
[patent_app_country] => US
[patent_app_date] => 2008-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5922
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20090098203.pdf
[firstpage_image] =>[orig_patent_app_number] => 12122232
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/122232 | Mucoadhesive Tetracycline Formulations | May 15, 2008 | Abandoned |
Array
(
[id] => 4887750
[patent_doc_number] => 20080262082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'COMPOSITION CONTAINING S-(-)-TULIPALIN B OR ACETYLATED-S-(-)-TULIPALIN B'
[patent_app_type] => utility
[patent_app_number] => 12/105757
[patent_app_country] => US
[patent_app_date] => 2008-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6119
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262082.pdf
[firstpage_image] =>[orig_patent_app_number] => 12105757
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/105757 | COMPOSITION CONTAINING S-(-)-TULIPALIN B OR ACETYLATED-S-(-)-TULIPALIN B | Apr 17, 2008 | Abandoned |
Array
(
[id] => 4812752
[patent_doc_number] => 20080193383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION AND ATTENDANT SIDE EFFECTS OF MU OPIOID COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/098899
[patent_app_country] => US
[patent_app_date] => 2008-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20471
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193383.pdf
[firstpage_image] =>[orig_patent_app_number] => 12098899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/098899 | COMPOSITIONS AND METHODS FOR REDUCING RESPIRATORY DEPRESSION AND ATTENDANT SIDE EFFECTS OF MU OPIOID COMPOUNDS | Apr 6, 2008 | Abandoned |
Array
(
[id] => 5539832
[patent_doc_number] => 20090221637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'SOLID-STATE SALT ARGATROBAN FORMULATIONS AND METHODS FOR PRODUCING AND USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/040768
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5674
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20090221637.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040768
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040768 | SOLID-STATE SALT ARGATROBAN FORMULATIONS AND METHODS FOR PRODUCING AND USING THE SAME | Feb 28, 2008 | Abandoned |
Array
(
[id] => 4867569
[patent_doc_number] => 20080146628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'PRAMIPEXOLE FOR THE TREATMENT OF ADHD'
[patent_app_type] => utility
[patent_app_number] => 12/039243
[patent_app_country] => US
[patent_app_date] => 2008-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1741
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20080146628.pdf
[firstpage_image] =>[orig_patent_app_number] => 12039243
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/039243 | PRAMIPEXOLE FOR THE TREATMENT OF ADHD | Feb 27, 2008 | Abandoned |
Array
(
[id] => 4812899
[patent_doc_number] => 20080193530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF NON-CORONARY MICROVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/030699
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6381
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030699
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030699 | USE OF RANOLAZINE FOR THE TREATMENT OF NON-CORONARY MICROVASCULAR DISEASES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 4681886
[patent_doc_number] => 20080248112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-09
[patent_title] => 'USE OF RANOLAZINE FOR THE TREATMENT OF CORONARY MICROVASCULAR DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/030659
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7862
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20080248112.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030659 | USE OF RANOLAZINE FOR THE TREATMENT OF CORONARY MICROVASCULAR DISEASES | Feb 12, 2008 | Abandoned |
Array
(
[id] => 4746279
[patent_doc_number] => 20080090881
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE AND METFORMIN'
[patent_app_type] => utility
[patent_app_number] => 11/953133
[patent_app_country] => US
[patent_app_date] => 2007-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3698
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090881.pdf
[firstpage_image] =>[orig_patent_app_number] => 11953133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/953133 | TREATMENT OF DIABETES WITH THIAZOLIDINEDIONE AND METFORMIN | Dec 9, 2007 | Abandoned |
Array
(
[id] => 4664317
[patent_doc_number] => 20080255224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'PHARMACOLOGICAL TREATMENT OF PSORIASIS'
[patent_app_type] => utility
[patent_app_number] => 11/952629
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4034
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20080255224.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952629
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952629 | PHARMACOLOGICAL TREATMENT OF PSORIASIS | Dec 6, 2007 | Abandoned |
Array
(
[id] => 4746292
[patent_doc_number] => 20080090894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-17
[patent_title] => 'Transdermal migraine therapy'
[patent_app_type] => utility
[patent_app_number] => 11/999093
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10399
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20080090894.pdf
[firstpage_image] =>[orig_patent_app_number] => 11999093
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/999093 | Transdermal migraine therapy | Dec 2, 2007 | Abandoned |
Array
(
[id] => 4718712
[patent_doc_number] => 20080241234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL'
[patent_app_type] => utility
[patent_app_number] => 11/943127
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 37037
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241234.pdf
[firstpage_image] =>[orig_patent_app_number] => 11943127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/943127 | PHARMACEUTICAL FORMULATIONS OF AN ANHYDRATE CRYSTAL FORM OF 2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL | Nov 19, 2007 | Abandoned |
Array
(
[id] => 4880428
[patent_doc_number] => 20080153811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-26
[patent_title] => 'Methods of Treating Cognitive Impairment and Dementia'
[patent_app_type] => utility
[patent_app_number] => 11/935081
[patent_app_country] => US
[patent_app_date] => 2007-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 30632
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0153/20080153811.pdf
[firstpage_image] =>[orig_patent_app_number] => 11935081
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/935081 | Methods of Treating Cognitive Impairment and Dementia | Nov 4, 2007 | Abandoned |
Array
(
[id] => 4903490
[patent_doc_number] => 20080112903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-15
[patent_title] => 'Topical Oral Care Compositions'
[patent_app_type] => utility
[patent_app_number] => 11/932097
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6627
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0112/20080112903.pdf
[firstpage_image] =>[orig_patent_app_number] => 11932097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/932097 | Topical Oral Care Compositions | Oct 30, 2007 | Abandoned |